Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer.
Saved in:
| Title: | Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer. |
|---|---|
| Authors: | Lindström LS; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden., Yau C; Department of Surgery, University of California San Francisco, San Francisco, CA.; Buck Institute for Research on Aging, Novato, CA., Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Thompson CK; Department of Surgery, University of California San Francisco, San Francisco, CA., Hoadley KA; Department of Genetics, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC., Van't Veer LJ; Department of Pathology, University of California San Francisco, San Francisco, CA.; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA., Balassanian R; Department of Pathology, University of California San Francisco, San Francisco, CA., Bishop JW; Center for Comparative Medicine, Department of Pathology and Laboratory Medicine, University of California Davis, Davis, CA., Carpenter PM; Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA.; Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, CA., Chen YY; Department of Pathology, University of California San Francisco, San Francisco, CA., Datnow B; Department of Pathology and Laboratory Medicine, University of California San Diego, La Jolla, CA., Hasteh F; Department of Pathology and Laboratory Medicine, University of California San Diego, La Jolla, CA., Krings G; Department of Pathology, University of California San Francisco, San Francisco, CA., Lin F; Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, CA., Zhang Y; Center for Comparative Medicine, Department of Pathology and Laboratory Medicine, University of California Davis, Davis, CA., Nordenskjöld B; Department of Clinical and Experimental Medicine and Department of Oncology, Linköping University, Linköping, Sweden., Stål O; Department of Clinical and Experimental Medicine and Department of Oncology, Linköping University, Linköping, Sweden., Benz CC; Department of Surgery, University of California San Francisco, San Francisco, CA.; Buck Institute for Research on Aging, Novato, CA., Fornander T; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Borowsky AD; Center for Comparative Medicine, Department of Pathology and Laboratory Medicine, University of California Davis, Davis, CA., Esserman LJ; Department of Surgery, University of California San Francisco, San Francisco, CA. |
| Corporate Authors: | STO Trialists Group |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2018 Jul 01; Vol. 110 (7), pp. 726-733. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
